FDA Issues Draft Guidance on Pharmacology Considerations for Neonatal Studies

Drug Industry Daily
Researchers should use innovative approaches and all information available when designing a neonatal study, as neonates come with serious considerations, such as a limited amount of circulating blood and rapid and varying rates of maturation, the agency advises in draft guidance.

To View This Article:


Subscribe To Drug Industry Daily